KBC and SR One lead €40m Ablynx financing

KBC Private Equity, a Belgian private equity firm, has made its second investment in a Belgian biotechnology firm this week by leading a €40m Series financing for Ablynx, which develops protein products for serious diseases including Alzheimer’s.

Share this